Arena Pharmaceuticals Inc. (ARNA) Plunges 8.38% on March 15

Equities Staff  |

Arena Pharmaceuticals Inc. (ARNA) had a rough trading day for Thursday March 15 as shares tumbled 8.38%, or a loss of $-3.02 per share, to close at $33.01. After opening the day at $36.24, shares of Arena Pharmaceuticals Inc. traded as high as $36.67 and as low as $31.55. Volume was 2.02 million shares over 14,671 trades, against an average daily volume of 551,110 shares and a total float of 39.26 million.

As a result of the decline, Arena Pharmaceuticals Inc. now has a market cap of $1.3 billion. In the last year, shares of Arena Pharmaceuticals Inc. have traded between a range of $44.50 and $11.30, and its 50-day SMA is currently $39.01 and 200-day SMA is $27.58.

For a complete fundamental analysis of Arena Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for ARNA.

Want to invest with the experts? Subscribe to Equities Premium newsletters today! Visit to learn more about Guild Investment’s Market Commentary and Adam Sarhan’s Find Leading Stocks today.

Arena Pharmaceuticals Inc is a biopharmaceutical company. The Company is engaged in discovering, developing and commercializing novel drugs that target G protein-coupled receptors, or GPCRs, to address unmet medical needs.

Arena Pharmaceuticals Inc. is based out of San Diego, CA and has some 106 employees. Its CEO is .

Arena Pharmaceuticals Inc. is a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Arena Pharmaceuticals Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ARNA’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Trending Articles

Cisco Down 12% in Premarket Trading Thursday After Top Line Miss and Lower Forecast
Under Armour CEO Patrik Frisk To Step Down in Surprise Announcement
Target Hits 52-Week Low After Missing Badly on First Quarter Earnings
DLocal Posts Record Q1, Fifth Consecutive 100%+ Revenue Growth Quarter
Another Crypto Winter Wipes Out Billions in Market Value
Inflation + Recession = Recipe for Volatility
Twitter Down 13% in Premarket Trading Friday as Musk Puts Deal on Hold

Market Movers

Sponsored Financial Content